Barts and The London, School of Medicine and Dentistry

Describe the mechanisms of action, pharmacokinetics, adverse effects and limitations of drugs used in the treatment of Parkinson’s disease (e.g. L-DOPA, dopaminergic agonists, cholinergic antagonists, MAOB inhibitors).

Level

This learning outcome is a primary level outcome.